| 產(chǎn)品名稱(chēng) |
Vaccinia virus |
| 商品貨號(hào) |
B208436 |
| Classification |
Poxviridae, Orthopoxvirus |
| Agent |
Vaccinia virus |
| Strain |
vTF7HB-1 [recombinant Vaccinia virus, strain Wr] |
| Biosafety Level |
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Isolation |
Constructed in vitro |
| Product Format |
frozen |
| Storage Conditions |
-60°C or colder |
| Disclosure |
This material is cited in a US or other Patent and may not be used to
infringe the claims. Depending on the wishes of the Depositor, ATCC may be
required to inform the Patent Depositor of the party to which the material was
furnished. This material may not have been produced or characterized by ATCC. |
| Comments |
Contains hepatitis B surface antigen gene regulated by bacteriophage T[7] promoter. |
| Effect on Host |
Cytopathic effects in tissue culture |
| Name of Depositor |
NIH, B Moss, NIH |
| U.S. Patent |
|
| U.S. Patent Number |
|
| Source |
Constructed in vitro |
